《新股表現》萬寶盛華(02180.HK)暗盤收10.92元高上市價10.3%
根據輝立交易平台顯示,明天掛牌的萬寶盛華(02180.HK)暗盤開報10.9元,最多漲31.3%高見13元,收報10.92元,較上市價9.9元,高10.3%或1.02元;成交232萬股,涉資2,570萬元。不計手續費,每手250股賬面賺255元。
萬寶盛華為人力資源解決方案供應商。是次上市共發售5,000萬股,其中10%公開發售獲約3.7倍超購,股份以招股範圍(9.9-12.6元)下限定價,料集資淨額4.516億元,主要用作進一步擴大業務規模和市場份額、投資研發、增強技術能力與發展數字人力資源平台、尋求策略性併購活動,以及進一步投資品牌建設和數字營銷等。上市獨家保薦人華泰金融香港。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.